Lab Corp Faces Class Action Over Surprise Billing Practices

Lab Corp Faces Class Action Over Surprise Billing Practices

LabCorp, one of the nation's largest clinical laboratory networks, is facing a significant class action lawsuit alleging the company has systematically engaged in surprise billing practices that violate federal consumer protection laws and state insurance regulations. The lawsuit, filed in federal court in North Carolina in early 2024, claims that millions of patients received unexpected bills after undergoing lab tests ordered by their physicians, even when those tests were performed at in-network facilities.

What the Lawsuit Alleges

The class action complaint, brought on behalf of patients who received surprise bills from LabCorp between 2020 and 2024, contends that the company has deliberately misrepresented its network status to patients and their insurance providers. According to the filing, LabCorp frequently performs laboratory services at facilities that appear to be in-network based on patient insurance cards and provider directories, yet bills patients out-of-network rates after the services are rendered.

The lawsuit identifies several problematic practices:

• Misrepresentation of network status: Patients relied on provider directories and insurance information that listed LabCorp locations as in-network, only to later receive bills reflecting out-of-network charges.
• Balance billing violations: The company allegedly charged patients the difference between what insurance paid and LabCorp's full billed amount, violating protections under the Affordable Care Act.
• Failure to obtain informed consent: Patients were not adequately informed that they might receive surprise bills before services were rendered.
• Deceptive billing practices: The complaint alleges LabCorp used confusing billing statements and collection letters to pressure patients into paying inflated out-of-network rates.

Why This Matters for Consumers

Surprise medical billing has emerged as one of the most persistent complaints in the healthcare system. While federal regulations have attempted to limit surprise billing in emergency situations and certain elective procedures, laboratory services have largely remained outside of these protections. LabCorp's dominance in the clinical lab market—the company processes approximately 2 billion lab tests annually—means that a significant portion of the American population may be affected by these alleged practices.

The Financial Protection Bureau and the Department of Health and Human Services have identified surprise billing from laboratory services as a growing problem, particularly because patients typically have no say in which lab processes their samples. When a physician orders blood work or other lab tests, patients often cannot choose where the sample is sent, making it difficult to avoid out-of-network labs entirely.

According to patient advocacy groups, surprise lab bills frequently range from $100 to several thousand dollars, depending on the complexity of the tests ordered. For uninsured or underinsured patients, these unexpected charges can be devastating and may force difficult choices between paying medical bills and covering other essential expenses.

LabCorp's Response and Current Status

LabCorp has not publicly commented on the specific allegations in the class action, though the company has previously maintained that it complies with all applicable federal and state billing regulations. In response to prior billing complaints, LabCorp stated that surprise bills often result from complex insurance coverage issues and that patients who receive unexpected bills can contact the company's patient advocate office to discuss payment options.

The case is currently in the discovery phase, with both parties exchanging documents and evidence. No settlement has been reached, and no trial date has been set. Legal experts suggest that the case could take 18 to 24 months to reach resolution, either through settlement negotiations or at trial.

How This Fits Into Broader Billing Reform Efforts

This lawsuit arrives amid increasing pressure on healthcare providers to curtail surprise billing. In 2021, the federal Surprise Billing Rule went into effect, designed to protect patients from unexpected out-of-network charges in emergency situations and from out-of-network providers at in-network facilities. However, the rule has significant gaps, particularly regarding laboratory and pathology services ordered in non-emergency settings.

Several states have enacted their own surprise billing protections, but enforcement has been inconsistent. This class action represents an attempt to hold LabCorp accountable under existing consumer protection statutes, including the Federal Trade Commission Act and state consumer fraud laws, rather than relying solely on federal billing regulations.

Who May Be Affected

The class action covers patients who received bills from LabCorp for laboratory services performed between January 1, 2020, and the present. Preliminary estimates suggest the class could include millions of patients nationwide, though the final scope will depend on court rulings on what qualifies as a valid class member. Patients may be included even if they paid the bill, settled with LabCorp, or had the debt sent to collections.

What Affected Consumers Should Know

If you received a surprise bill from LabCorp in recent years, you may be eligible to participate in this class action lawsuit. Here's what consumers should understand about their options:

• Documentation matters: Gather any bills, explanation of benefits statements, and correspondence from LabCorp or collection agencies related to laboratory charges.
• Class action process: If the lawsuit proceeds and reaches a settlement or verdict in the plaintiffs' favor, eligible class members will typically be notified and may receive compensation without taking additional legal action.
• Statute of limitations: Most states have time limits for filing consumer protection claims, typically ranging from two to four years, though the class action typically freezes these deadlines for class members.
• No cost to participate: Class members do not pay fees to join a class action; any attorney fees typically come from the settlement or judgment amount.

Looking Ahead

Legal observers expect this case could set important precedent regarding laboratory companies' obligations to maintain accurate network status information and disclose billing practices to patients. If plaintiffs prevail, the ruling could force LabCorp and other large laboratory networks to implement significant changes to their billing and patient communication practices.

The outcome may also influence regulatory action. The Centers for Medicare & Medicaid Services has indicated interest in extending surprise billing protections to laboratory services, and a successful class action could accelerate those efforts.

Consumers who believe they have been harmed by surprise lab bills are encouraged to stay informed about developments in this case and to consult with a qualified attorney about their individual circumstances if they have questions about pending bills or collection notices from LabCorp.